I don't think that our present congress can pass this long awaited bill. I believe that big multi-national companies are doing so hard in lobbying the congressmen not to pass this bill. There are two points that I wish to emphasize in this blog. First is that, our corrupt and bureaucratic government cannot pass this act and secondly the battle for affordable medicines cannot be solved in our congress.
Our congress cannot pass this law, it's good if they cannot do it for a certain reason. What will happen to the Filipino people if they 'will' not pass this law? In other words, if they intend not to pass it... Currently the bill is on its final reading, and currently also, big multi-national companies are lobbying so hard not to have this bill enacted. Why is that do? The answer is very simple, this will affect their market sales and will lower their profit. Just recently, big multi-national companies are establishing a generic counterpart of their company. RiteMed is a counterpart of Unilab, and I heard also that Sanofi Aventis is having one also, and many more... How will this bill pass? I don't think it will be enacted...
To solve the higher prices of medicines that the Filipinos carry cannot be resolved by the congress itself. Unless our congressman would be sincere enough in representing their constituents, whom i am sure would want a lower priced medicine, this bill cannot pass the readings. The Filipinos won't win the battle, only the opportunist representatives would win. Winning this battle can be achieved through marketing.
Seeking for options so that quality treatment may not have to be expensive is the Vision of Mr. Rodolfo I. Gracia, founder of GX International, Inc. He envisioned this as a weapon in winning the battle for affordable and top quality medicines. The company is hundred percent owned by Filipino businessmen who believe that Filipinos themselves are the only people who can serve the Filipinos at best.
Cheaper medicine Bill? No need of that. Support for the growth of GX International, Inc. Currently the company ranks third in the country's Filipino owned Pharmaceutical companies. In 1994, it was at the 500th place in the ranking of the countries top pharmaceutical companies. Right now, in more than ten years the company humbly ranks 17th (including the multi-nationals).
